IMI2-PainCare-BioPain-RCT1: study protocol for a randomized, double-blind, placebo-controlled, crossover, multi-center trial in healthy subjects to investigate the effects of lacosamide, pregabalin, and tapentadol on biomarkers of pain processing observed by peripheral nerve excitability testing (NET)
IMI2-PainCare-BioPain-RCT1:一项随机、双盲、安慰剂对照、交叉、多中心试验的研究方案,旨在研究拉考沙胺、普瑞巴林和他喷他多对通过周围神经兴奋性测试 (NET) 观察到的疼痛处理生物标志物的影响,受试者为健康人群。
期刊:Trials
影响因子:2
doi:10.1186/s13063-022-06087-1
Nochi, Zahra; Pia, Hossein; Bloms-Funke, Petra; Boesl, Irmgard; Caspani, Ombretta; Chapman, Sonya C; Fardo, Francesca; Genser, Bernd; Goetz, Marcus; Kostenko, Anna V; Leone, Caterina; Li, Thomas; Mouraux, André; Pelz, Bernhard; Pogatzki-Zahn, Esther; Schilder, Andreas; Schnetter, Erik; Schubart, Karin; Stouffs, Alexandre; Tracey, Irene; Troconiz, Iñaki F; Truini, Andrea; Van Niel, Johannes; Vela, Jose Miguel; Vincent, Katy; Vollert, Jan; Wanigasekera, Vishvarani; Wittayer, Matthias; Tankisi, Hatice; Finnerup, Nanna B; Phillips, Keith G; Treede, Rolf-Detlef